22,619 Shares in Waters Corporation $WAT Acquired by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. bought a new position in Waters Corporation (NYSE:WAT) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 22,619 shares of the medical instruments supplier’s stock, valued at approximately $8,483,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Madison Asset Management LLC raised its stake in shares of Waters by 2.6% during the second quarter. Madison Asset Management LLC now owns 279,856 shares of the medical instruments supplier’s stock worth $104,957,000 after acquiring an additional 7,207 shares in the last quarter. Danske Bank A S boosted its stake in shares of Waters by 1.0% in the 2nd quarter. Danske Bank A S now owns 42,179 shares of the medical instruments supplier’s stock valued at $15,819,000 after purchasing an additional 430 shares in the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Waters in the 2nd quarter valued at $4,373,000. Foster & Motley Inc. bought a new position in shares of Waters during the 2nd quarter valued at $215,000. Finally, Figure 8 Investment Strategies LLC purchased a new position in Waters in the 2nd quarter worth $2,965,000. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Stifel Nicolaus set a $420.00 price target on shares of Waters in a research note on Wednesday, August 5th. UBS Group raised their price objective on Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Piper Sandler began coverage on Waters in a report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price objective on the stock. Evercore reissued an “outperform” rating and issued a $420.00 target price on shares of Waters in a research note on Wednesday, August 5th. Finally, Morgan Stanley set a $430.00 target price on Waters in a report on Wednesday, August 5th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $420.35.

Waters Stock Performance

Shares of NYSE:WAT opened at $416.45 on Thursday. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $379.73 and a 200-day moving average price of $346.54. The company has a market cap of $40.92 billion, a price-to-earnings ratio of 103.85, a price-to-earnings-growth ratio of 2.33 and a beta of 1.19. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $420.26.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%.The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same period last year, the firm earned $2.95 earnings per share. Waters’s quarterly revenue was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. As a group, equities analysts anticipate that Waters Corporation will post 14.57 EPS for the current year.

Insider Activity

In related news, Director Christopher A. Kuebler sold 3,626 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the transaction, the director owned 17,808 shares in the company, valued at $7,086,515.52. The trade was a 16.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.31% of the stock is owned by corporate insiders.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.